optochin tesst

Upload: tiberiu-domuncu

Post on 07-Apr-2018

216 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/6/2019 optochin tesst

    1/9

    OPTOCHIN TESTIssue no: 2.1 Issue date: 09.12.10 Issued by: Standards Unit, Department for Evaluations, Standards and Training Page no: 1 of 9

    BSOP TP 25i2.1This NSM should be used in conjunction with the series of other NSMs from the Health Protection Agency

    www.evaluations-standards.org.ukEmail: [email protected]

    NATIONAL STANDARD METHOD

    OPTOCHIN TEST

    BSOP TP 25

    Issued by Standards Unit, Department for Evaluations, Standards and TrainingCentre for Infections

  • 8/6/2019 optochin tesst

    2/9

    OPTOCHIN TESTIssue no: 2.1 Issue date: 09.12.10 Issued by: Standards Unit, Department for Evaluations, Standards and Training Page no: 2 of 9

    BSOP TP 25i2.1This NSM should be used in conjunction with the series of other NSMs from the Health Protection Agency

    www.evaluations-standards.org.ukEmail: [email protected]

    STATUS OF NATIONAL STANDARD METHODSNational Standard Methods, which include standard operating procedures (SOPs), algorithms andguidance notes, promote high quality practices and help to assure the comparability of diagnosticinformation obtained in different laboratories. This in turn facilitates standardisation of surveillanceunderpinned by research, development and audit and promotes public health and patient confidence in

    their healthcare services. The methods are well referenced and represent a good minimum standardfor clinical and public health microbiology. However, in using National Standard Methods, laboratoriesshould take account of local requirements and may need to undertake additional investigations. Themethods also provide a reference point for method development.

    National Standard Methods are developed, reviewed and updated through an open and wideconsultation process where the views of all participants are considered and the resulting documentsreflect the majority agreement of contributors.

    Representatives of several professional organisations, including those whose logos appear on the frontcover, are members of the working groups which develop National Standard Methods. Inclusion of anorganisations logo on the front cover implies support for the objectives and process of preparingstandard methods. The representatives participate in the development of the National Standard

    Methods but their views are not necessarily those of the entire organisation of which they are amember. The current list of participating organisations can be obtained by [email protected].

    The performance of standard methods depends on the quality of reagents, equipment, commercial andin-house test procedures. Laboratories should ensure that these have been validated and shown to befit for purpose. Internal and external quality assurance procedures should also be in place.

    Whereas every care has been taken in the preparation of this publication, the Health Protection Agencyor any supporting organisation cannot be responsible for the accuracy of any statement orrepresentation made or the consequences arising from the use of or alteration to any informationcontained in it. These procedures are intended solely as a general resource for practising professionalsin the field, operating in the UK, and specialist advice should be obtained where necessary. If you

    make any changes to this publication, it must be made clear where changes have been made to theoriginal document. The Health Protection Agency (HPA) should at all times be acknowledged.

    The HPA is an independent organisation dedicated to protecting peoples health. It brings together theexpertise formerly in a number of official organisations. More information about the HPA can be foundat www.hpa.org.uk.

    The HPA aims to be a fully Caldicott compliant organisation. It seeks to take every possible precautionto prevent unauthorised disclosure of patient details and to ensure that patient-related records are keptunder secure conditions

    1.

    More details can be found on the website at www.evaluations-standards.org.uk. Contributions to thedevelopment of the documents can be made by contacting [email protected].

    The reader is informed that all taxonomy in this document was correct at time of issue.

    Suggested citation for this document:Health Protection Agency (2010). Optochin Test. National Standard Method BSOP TP 25 Issue 2.1.http://www.hpa-standardmethods.org.uk/pdf_sops.asp.

    Please note the references are now formatted using Reference Manager software. If you alter or deletetext without Reference Manager installed on your computer, the references will not be updated automatically.

  • 8/6/2019 optochin tesst

    3/9

    OPTOCHIN TESTIssue no: 2.1 Issue date: 09.12.10 Issued by: Standards Unit, Department for Evaluations, Standards and Training Page no: 3 of 9

    BSOP TP 25i2.1This NSM should be used in conjunction with the series of other NSMs from the Health Protection Agency

    www.evaluations-standards.org.ukEmail: [email protected]

    INDEX

    STATUS OF NATIONAL STANDARD METHODS .................................................................2

    INDEX ......................................................................................................................................3

    AMENDMENT PROCEDURE ..................................................................................................4

    SCOPE OF DOCUMENT.........................................................................................................5

    INTRODUCTION......................................................................................................................5

    TECHNICAL INFORMATION/LIMITATIONS ..........................................................................5

    1 SAFETY CONSIDERATIONS ...........................................................................................6

    2 REAGENTS AND EQUIPMENT........................................................................................6

    3 QUALITY CONTROL ORGANISMS .................................................................................6

    4 PROCEDURE AND RESULTS .........................................................................................6

    4.1 PURE COLONY ..............................................................................................................64.2 SPECIMEN ....................................................................................................................6

    5 ACKNOWLEDGEMENTS AND CONTACTS....................................................................7

    APPENDIX: OPTOCHIN TEST................................................................................................8

    REFERENCES.........................................................................................................................9

  • 8/6/2019 optochin tesst

    4/9

    OPTOCHIN TESTIssue no: 2.1 Issue date: 09.12.10 Issued by: Standards Unit, Department for Evaluations, Standards and Training Page no: 4 of 9

    BSOP TP 25i2.1This NSM should be used in conjunction with the series of other NSMs from the Health Protection Agency

    www.evaluations-standards.org.ukEmail: [email protected]

    AMENDMENT PROCEDURE

    Controlled documentreference

    BSOP TP 25

    Controlled document title Optochin Test

    Each National Standard Method has an individual record of amendments. The current amendmentsare listed on this page. The amendment history is available from [email protected].

    On issue of revised or new pages each controlled document should be updated by the copyholder inthe laboratory.

    AmendmentNumber/Date

    Issue no.Discarded

    InsertIssueno.

    Page Section(s) involved Amendment

    2/

    01/12/2010

    1.1 2 5 Optochin Test Reworded

    Report of occasional Optochinresistant strain added toTechnical Information andLimitations

    7 Acknowledgementsand Contacts

    Contact details added

    8 Appendix Flowchart added

    9 References Revised

    3/

    9/12/2010

    2 2.1 6 Quality control

    organisms

    Negaitive control amended

    from Streptococcus viridanstoStreptococcus mitis

    8 Appendix Flowchart amended to correct14 mm radius to 14 mmdiameter zone size

  • 8/6/2019 optochin tesst

    5/9

    OPTOCHIN TESTIssue no: 2.1 Issue date: 09.12.10 Issued by: Standards Unit, Department for Evaluations, Standards and Training Page no: 5 of 9

    BSOP TP 25i2.1This NSM should be used in conjunction with the series of other NSMs from the Health Protection Agency

    www.evaluations-standards.org.ukEmail: [email protected]

    OPTOCHIN TEST

    SCOPE OF DOCUMENTSusceptibility to optochin (ethlyhydrocupreine hydrochloride) is a simple and reliable method ofdifferentiating Streptococcus pneumoniaefrom other alpha-haemolytic streptococci

    2.

    INTRODUCTIONThe optochin test detects an organisms susceptibility to the chemical optochin. The chemical teststhe fragility of the bacterial cell membrane and causes S. pneumoniae to lyse due to changes insurface tension.

    The optochin test is widely used in the form of filter paper discs, impregnated with ethylhydrocupreine

    hydrochloride, which are applied directly to inoculated plates before incubation3,4.

    TECHNICAL INFORMATION/LIMITATIONSSome viridans streptococci may produce a small zone of inhibition, ie

  • 8/6/2019 optochin tesst

    6/9

    OPTOCHIN TESTIssue no: 2.1 Issue date: 09.12.10 Issued by: Standards Unit, Department for Evaluations, Standards and Training Page no: 6 of 9

    BSOP TP 25i2.1This NSM should be used in conjunction with the series of other NSMs from the Health Protection Agency

    www.evaluations-standards.org.ukEmail: [email protected]

    1 SAFETY CONSIDERATIONS7-13

    Refer to current guidance on the safe handling of all organisms and reagents documented inthis National Standard Method.

    All work likely to generate aerosols must be performed in a microbiological safety cabinet.

    The above guidance should be supplemented with local COSHH and risk assessments.

    Compliance with postal and transport regulations is essential.

    2 REAGENTS AND EQUIPMENT14

    Filter paper discs impregnated with 5g of ethylhydrocupreine hydrochloride.

    Bacteriological straight wire/loop (preferably nichrome) or disposable alternative.

    3 QUALITY CONTROL ORGANISMS

    15

    Positive control Streptococcus pneumoniaeNCTC 12977Negative control Streptococcus mitisNCTC 10712

    NB: Strains are not validated by the HPA National Collection of Type Cultures to give thisresult

    4 PROCEDURE AND RESULTS

    4.1 PURE COLONY

    Streak a blood plate with the organism to be tested

    Place an optochin disc in the centre of the inoculum

    Incubate at 35-37C for 18-24 hours in 5% CO2

    Examine for zones of inhibition

    4.2 SPECIMEN

    Streak the specimen on a blood agar plate

    Place an optochin disc on the edge of the primary inoculum

    Incubate at 35-37C for 18-24 hours in 5% CO2

    Examine for zones of inhibition.

    Positive result Zone of inhibition of 14mm diameter indicating test organism isS. pneumoniae.

    Negative result No zone of inhibition indicating test organism is not S. pneumoniae.A zone < 14mm diameter please see Technical Information sectionfor further test requirements.

  • 8/6/2019 optochin tesst

    7/9

    OPTOCHIN TESTIssue no: 2.1 Issue date: 09.12.10 Issued by: Standards Unit, Department for Evaluations, Standards and Training Page no: 7 of 9

    BSOP TP 25i2.1This NSM should be used in conjunction with the series of other NSMs from the Health Protection Agency

    www.evaluations-standards.org.ukEmail: [email protected]

    5 ACKNOWLEDGEMENTS AND CONTACTSThis National Standard Method has been developed, reviewed and revised by the NationalStandard Methods Working Group for Clinical Bacteriology(http://www.hpa-standardmethods.org.uk/wg_bacteriology.asp). The contributions of manyindividuals in clinical bacteriology laboratories and specialist organisations who have providedinformation and comment during the development of this document, and final editing by the

    Medical Editor are acknowledged.

    The National Standard Methods are issued by Standards Unit, Department for Evaluations,Standards and Training, Centre for Infections, Health Protection Agency, London.

    For further information please contact us at:

    Standards UnitDepartment for Evaluations, Standards and TrainingCentre for InfectionsHealth Protection AgencyColindaleLondonNW9 5EQ

    E-mail: [email protected]

  • 8/6/2019 optochin tesst

    8/9

    OPTOCHIN TESTIssue no: 2.1 Issue date: 09.12.10 Issued by: Standards Unit, Department for Evaluations, Standards and Training Page no: 8 of 9

    BSOP TP 25i2.1This NSM should be used in conjunction with the series of other NSMs from the Health Protection Agency

    www.evaluations-standards.org.ukEmail: [email protected]

    APPENDIX: OPTOCHIN TEST

    Pure colony Specimen

    Streak a blood agar plate with

    organism to be tested. Placeoptochin disc in centre of

    inoculum

    Incubate at 35-37 C for

    18-24 hrs in 5% CO2

    Positive

    Zone of inhibition of

    = 14mm radiusfromthe edge of disc

    Negative

    No zone of inhibition

    or < 14mm etc

  • 8/6/2019 optochin tesst

    9/9